These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 34867774

  • 1. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.
    Langer I, Latek D.
    Front Endocrinol (Lausanne); 2021; 12():711906. PubMed ID: 34867774
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 5. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 6. A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.
    Ramos-Álvarez I, Mantey SA, Nakamura T, Nuche-Berenguer B, Moreno P, Moody TW, Maderdrut JL, Coy DH, Jensen RT.
    Peptides; 2015 Apr; 66():26-42. PubMed ID: 25698233
    [Abstract] [Full Text] [Related]

  • 7. Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury.
    Broome ST, Mandwie M, Gorrie CA, Musumeci G, Marzagalli R, Castorina A.
    J Mol Neurosci; 2023 Oct; 73(9-10):724-737. PubMed ID: 37646964
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor.
    Tasma Z, Rees TA, Guo S, Tan S, O'Carroll SJ, Faull RLM, Curtis MA, Christensen SL, Hay DL, Walker CS.
    Br J Pharmacol; 2024 Aug; 181(15):2655-2675. PubMed ID: 38616050
    [Abstract] [Full Text] [Related]

  • 12. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors.
    Cunha-Reis D, Aidil-Carvalho Mde F, Ribeiro JA.
    Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659
    [Abstract] [Full Text] [Related]

  • 13. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Busto R, Sánchez-Chapado M, Guijarro LG, Prieto JC.
    Cell Signal; 1999 Nov; 11(11):813-9. PubMed ID: 10617284
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K, Connell TD, Higgins D.
    J Neurosci; 2002 Aug 01; 22(15):6560-9. PubMed ID: 12151535
    [Abstract] [Full Text] [Related]

  • 18. Signal Transduction by VIP and PACAP Receptors.
    Langer I, Jeandriens J, Couvineau A, Sanmukh S, Latek D.
    Biomedicines; 2022 Feb 09; 10(2):. PubMed ID: 35203615
    [Abstract] [Full Text] [Related]

  • 19. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S.
    Clin Cancer Res; 2004 Dec 15; 10(24):8235-42. PubMed ID: 15623599
    [Abstract] [Full Text] [Related]

  • 20. Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery.
    Tasma Z, Siow A, Harris PWR, Brimble MA, Hay DL, Walker CS.
    Br J Pharmacol; 2022 Feb 15; 179(3):435-453. PubMed ID: 34612509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.